| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor, Insulin | 30 | 2020 | 94 | 7.520 |
Why?
|
| Retina | 35 | 2025 | 434 | 7.190 |
Why?
|
| Retinal Degeneration | 9 | 2025 | 150 | 4.440 |
Why?
|
| Retinal Rod Photoreceptor Cells | 15 | 2024 | 90 | 4.290 |
Why?
|
| Phosphatidylinositol 3-Kinases | 22 | 2025 | 136 | 3.960 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 9 | 2021 | 24 | 3.450 |
Why?
|
| Proto-Oncogene Proteins c-akt | 15 | 2025 | 156 | 3.280 |
Why?
|
| Retinal Cone Photoreceptor Cells | 10 | 2018 | 126 | 3.040 |
Why?
|
| Signal Transduction | 25 | 2025 | 1433 | 2.740 |
Why?
|
| Phosphatidylinositols | 6 | 2021 | 25 | 2.710 |
Why?
|
| Mice | 48 | 2025 | 4655 | 2.580 |
Why?
|
| Animals | 79 | 2025 | 10416 | 2.570 |
Why?
|
| Mice, Knockout | 30 | 2024 | 847 | 2.440 |
Why?
|
| Light | 14 | 2015 | 118 | 2.360 |
Why?
|
| Photoreceptor Cells | 5 | 2022 | 36 | 2.340 |
Why?
|
| Pyruvate Kinase | 4 | 2020 | 10 | 2.340 |
Why?
|
| Photoreceptor Cells, Vertebrate | 5 | 2025 | 67 | 2.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 9 | 2021 | 162 | 1.890 |
Why?
|
| Rod Cell Outer Segment | 10 | 2013 | 42 | 1.790 |
Why?
|
| Rhodopsin | 7 | 2022 | 40 | 1.680 |
Why?
|
| Phosphorylation | 25 | 2021 | 578 | 1.660 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 6 | 2015 | 57 | 1.620 |
Why?
|
| Proteins | 5 | 2013 | 252 | 1.590 |
Why?
|
| Cell Survival | 14 | 2018 | 408 | 1.540 |
Why?
|
| Diabetic Retinopathy | 5 | 2025 | 110 | 1.470 |
Why?
|
| Eye Proteins | 10 | 2018 | 205 | 1.450 |
Why?
|
| Rats | 27 | 2020 | 1568 | 1.450 |
Why?
|
| Genetic Therapy | 3 | 2018 | 123 | 1.420 |
Why?
|
| Nuclear Proteins | 6 | 2016 | 247 | 1.280 |
Why?
|
| Acyltransferases | 10 | 2004 | 24 | 1.190 |
Why?
|
| Rats, Sprague-Dawley | 21 | 2020 | 544 | 1.170 |
Why?
|
| src-Family Kinases | 4 | 2016 | 71 | 1.140 |
Why?
|
| Phosphoprotein Phosphatases | 3 | 2016 | 39 | 0.940 |
Why?
|
| Cattle | 18 | 2018 | 389 | 0.930 |
Why?
|
| Vesicular Transport Proteins | 1 | 2025 | 34 | 0.910 |
Why?
|
| Microfilament Proteins | 1 | 2025 | 31 | 0.910 |
Why?
|
| Vision, Ocular | 3 | 2014 | 27 | 0.910 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2024 | 15 | 0.890 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 6 | 3 | 2020 | 8 | 0.850 |
Why?
|
| HEK293 Cells | 8 | 2018 | 187 | 0.810 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2022 | 48 | 0.810 |
Why?
|
| Retinal Pigment Epithelium | 6 | 2024 | 97 | 0.790 |
Why?
|
| Mice, Inbred C57BL | 9 | 2025 | 1573 | 0.780 |
Why?
|
| Retinal Photoreceptor Cell Outer Segment | 3 | 2020 | 18 | 0.780 |
Why?
|
| Nanoparticles | 2 | 2018 | 288 | 0.760 |
Why?
|
| Ribosomes | 1 | 2022 | 31 | 0.760 |
Why?
|
| cis-trans-Isomerases | 4 | 2018 | 27 | 0.750 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2012 | 97 | 0.740 |
Why?
|
| Liposomes | 3 | 2018 | 145 | 0.710 |
Why?
|
| Promoter Regions, Genetic | 3 | 2018 | 345 | 0.700 |
Why?
|
| Tyrosine | 5 | 2010 | 92 | 0.690 |
Why?
|
| Retinitis Pigmentosa | 3 | 2018 | 30 | 0.690 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 3 | 2025 | 7 | 0.690 |
Why?
|
| Neuroprotection | 2 | 2022 | 14 | 0.680 |
Why?
|
| Gene Expression Regulation, Enzymologic | 6 | 2020 | 94 | 0.680 |
Why?
|
| Protein Binding | 10 | 2021 | 657 | 0.680 |
Why?
|
| Vitreoretinopathy, Proliferative | 1 | 2020 | 3 | 0.680 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2020 | 21 | 0.670 |
Why?
|
| Vitreous Body | 1 | 2020 | 22 | 0.670 |
Why?
|
| Vimentin | 1 | 2020 | 28 | 0.670 |
Why?
|
| Humans | 37 | 2025 | 28168 | 0.670 |
Why?
|
| Gene Transfer Techniques | 2 | 2018 | 67 | 0.670 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2022 | 301 | 0.660 |
Why?
|
| Retinal Photoreceptor Cell Inner Segment | 1 | 2020 | 4 | 0.660 |
Why?
|
| Membrane Proteins | 2 | 2016 | 485 | 0.650 |
Why?
|
| Mice, Inbred BALB C | 6 | 2020 | 276 | 0.630 |
Why?
|
| Cytoskeleton | 2 | 2009 | 44 | 0.620 |
Why?
|
| Electroretinography | 6 | 2020 | 178 | 0.610 |
Why?
|
| Insulin | 7 | 2010 | 315 | 0.610 |
Why?
|
| Cytoskeletal Proteins | 2 | 2021 | 42 | 0.610 |
Why?
|
| Gene Deletion | 5 | 2024 | 118 | 0.590 |
Why?
|
| Blotting, Western | 12 | 2017 | 513 | 0.570 |
Why?
|
| Receptor, IGF Type 1 | 3 | 2022 | 41 | 0.550 |
Why?
|
| Genetic Vectors | 1 | 2018 | 116 | 0.550 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 82 | 0.540 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2018 | 76 | 0.540 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 95 | 0.540 |
Why?
|
| Disease Models, Animal | 8 | 2020 | 1462 | 0.530 |
Why?
|
| Protein Transport | 6 | 2016 | 158 | 0.510 |
Why?
|
| Fossil Fuels | 1 | 2016 | 5 | 0.510 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 402 | 0.500 |
Why?
|
| Theranostic Nanomedicine | 1 | 2016 | 25 | 0.500 |
Why?
|
| Neurons | 4 | 2022 | 282 | 0.500 |
Why?
|
| Particulate Matter | 1 | 2016 | 17 | 0.500 |
Why?
|
| Transport Vesicles | 1 | 2016 | 8 | 0.500 |
Why?
|
| Cell Fractionation | 1 | 2016 | 19 | 0.500 |
Why?
|
| Retinal Ganglion Cells | 3 | 2022 | 26 | 0.490 |
Why?
|
| Phosphotyrosine | 3 | 2005 | 18 | 0.480 |
Why?
|
| Protein Structure, Tertiary | 6 | 2012 | 284 | 0.480 |
Why?
|
| Drug Carriers | 1 | 2016 | 115 | 0.470 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2015 | 15 | 0.470 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2015 | 2 | 0.470 |
Why?
|
| ras Proteins | 2 | 2012 | 43 | 0.470 |
Why?
|
| Molecular Sequence Data | 12 | 2013 | 1052 | 0.460 |
Why?
|
| Carrier Proteins | 4 | 2016 | 252 | 0.460 |
Why?
|
| Blindness | 1 | 2014 | 34 | 0.450 |
Why?
|
| Protein Subunits | 4 | 2010 | 44 | 0.450 |
Why?
|
| Myristic Acid | 3 | 2005 | 4 | 0.440 |
Why?
|
| Amino Acid Sequence | 11 | 2013 | 690 | 0.440 |
Why?
|
| Photic Stimulation | 5 | 2015 | 67 | 0.440 |
Why?
|
| Dark Adaptation | 1 | 2013 | 11 | 0.430 |
Why?
|
| Nanomedicine | 1 | 2014 | 62 | 0.430 |
Why?
|
| Hexokinase | 1 | 2013 | 16 | 0.420 |
Why?
|
| Protein Isoforms | 3 | 2018 | 119 | 0.420 |
Why?
|
| Light Signal Transduction | 2 | 2010 | 8 | 0.410 |
Why?
|
| Cell Membrane | 6 | 2018 | 260 | 0.410 |
Why?
|
| Apoptosis | 7 | 2018 | 774 | 0.400 |
Why?
|
| Receptor Cross-Talk | 1 | 2012 | 11 | 0.400 |
Why?
|
| Enzyme Inhibitors | 5 | 2012 | 250 | 0.400 |
Why?
|
| Cell Communication | 1 | 2013 | 68 | 0.390 |
Why?
|
| Enzyme Activation | 6 | 2015 | 267 | 0.390 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 2 | 2021 | 8 | 0.380 |
Why?
|
| Actins | 2 | 2009 | 96 | 0.380 |
Why?
|
| GRB7 Adaptor Protein | 1 | 2012 | 4 | 0.380 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2011 | 5 | 0.380 |
Why?
|
| Conserved Sequence | 1 | 2012 | 54 | 0.370 |
Why?
|
| Static Electricity | 1 | 2011 | 35 | 0.370 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2011 | 8 | 0.370 |
Why?
|
| Drug Design | 1 | 2012 | 63 | 0.360 |
Why?
|
| Organ Culture Techniques | 5 | 2010 | 56 | 0.360 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2009 | 96 | 0.350 |
Why?
|
| Mice, Transgenic | 5 | 2015 | 509 | 0.350 |
Why?
|
| Isoenzymes | 4 | 2020 | 86 | 0.340 |
Why?
|
| Mitochondria | 1 | 2013 | 366 | 0.330 |
Why?
|
| Oncogene Protein v-akt | 1 | 2010 | 8 | 0.330 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2010 | 27 | 0.330 |
Why?
|
| Gene Expression Regulation | 4 | 2020 | 633 | 0.320 |
Why?
|
| Cells, Cultured | 8 | 2017 | 985 | 0.320 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2010 | 38 | 0.320 |
Why?
|
| Integrases | 3 | 2018 | 39 | 0.320 |
Why?
|
| Male | 14 | 2020 | 13511 | 0.320 |
Why?
|
| Stress, Psychological | 2 | 2010 | 219 | 0.320 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2000 | 102 | 0.310 |
Why?
|
| Glycolysis | 2 | 2020 | 85 | 0.300 |
Why?
|
| Immunoblotting | 3 | 2020 | 123 | 0.300 |
Why?
|
| Immunohistochemistry | 6 | 2011 | 463 | 0.300 |
Why?
|
| Cyclic GMP | 3 | 2013 | 29 | 0.290 |
Why?
|
| Phosphoproteins | 2 | 2005 | 119 | 0.280 |
Why?
|
| Myocardial Reperfusion Injury | 3 | 2002 | 9 | 0.280 |
Why?
|
| Phosphatidylinositol Phosphates | 2 | 2022 | 11 | 0.280 |
Why?
|
| Calcium | 4 | 2011 | 235 | 0.270 |
Why?
|
| Phenotype | 2 | 2020 | 679 | 0.260 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2018 | 32 | 0.260 |
Why?
|
| Detergents | 1 | 2006 | 24 | 0.250 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 2 | 2018 | 34 | 0.240 |
Why?
|
| Protein Modification, Translational | 1 | 2005 | 1 | 0.240 |
Why?
|
| Palmitates | 1 | 2005 | 9 | 0.240 |
Why?
|
| Membrane Microdomains | 1 | 2006 | 39 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 330 | 0.230 |
Why?
|
| Occludin | 1 | 2024 | 11 | 0.230 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2005 | 140 | 0.220 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2022 | 16 | 0.220 |
Why?
|
| Lipids | 3 | 2014 | 208 | 0.210 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 2008 | 167 | 0.210 |
Why?
|
| Female | 7 | 2020 | 15192 | 0.200 |
Why?
|
| Kinetics | 5 | 2010 | 545 | 0.200 |
Why?
|
| DNA Primers | 3 | 2013 | 146 | 0.200 |
Why?
|
| Protein Interaction Mapping | 2 | 2018 | 34 | 0.200 |
Why?
|
| Phosphoinositide Phosphatases | 1 | 2022 | 3 | 0.190 |
Why?
|
| Flavoproteins | 1 | 2022 | 5 | 0.190 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 1 | 2022 | 5 | 0.190 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2022 | 20 | 0.190 |
Why?
|
| MicroRNAs | 2 | 2017 | 299 | 0.190 |
Why?
|
| Cell Line | 4 | 2017 | 694 | 0.190 |
Why?
|
| Glaucoma | 1 | 2022 | 53 | 0.190 |
Why?
|
| Second Messenger Systems | 2 | 2012 | 13 | 0.180 |
Why?
|
| beta-Crystallin A Chain | 1 | 2021 | 1 | 0.180 |
Why?
|
| Arrestin | 2 | 2011 | 11 | 0.180 |
Why?
|
| Cell Polarity | 1 | 2021 | 22 | 0.180 |
Why?
|
| Darkness | 2 | 2011 | 17 | 0.180 |
Why?
|
| Models, Molecular | 3 | 2012 | 453 | 0.180 |
Why?
|
| Endocytosis | 1 | 2021 | 89 | 0.180 |
Why?
|
| Nuclear Localization Signals | 2 | 2014 | 9 | 0.180 |
Why?
|
| ErbB Receptors | 1 | 2021 | 101 | 0.180 |
Why?
|
| Base Sequence | 2 | 2013 | 585 | 0.170 |
Why?
|
| Transducin | 2 | 2011 | 13 | 0.170 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2020 | 5 | 0.170 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2000 | 7 | 0.170 |
Why?
|
| Microscopy, Fluorescence | 2 | 2011 | 163 | 0.170 |
Why?
|
| Gliosis | 1 | 2020 | 17 | 0.170 |
Why?
|
| Glycerol | 1 | 2020 | 16 | 0.170 |
Why?
|
| DNA, Complementary | 3 | 2018 | 77 | 0.170 |
Why?
|
| Binding Sites | 1 | 2021 | 354 | 0.170 |
Why?
|
| Gallbladder Neoplasms | 1 | 2000 | 14 | 0.170 |
Why?
|
| Retinal Diseases | 1 | 2020 | 47 | 0.160 |
Why?
|
| Lactic Acid | 1 | 2020 | 92 | 0.160 |
Why?
|
| Epithelial Cells | 1 | 2021 | 247 | 0.160 |
Why?
|
| RNA | 1 | 2020 | 111 | 0.160 |
Why?
|
| Carcinoma | 1 | 2000 | 75 | 0.160 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2018 | 43 | 0.160 |
Why?
|
| Organ Specificity | 2 | 2010 | 82 | 0.160 |
Why?
|
| Animals, Genetically Modified | 2 | 2010 | 54 | 0.160 |
Why?
|
| Xenopus laevis | 2 | 2010 | 50 | 0.160 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 363 | 0.150 |
Why?
|
| Recombinant Proteins | 3 | 2018 | 414 | 0.150 |
Why?
|
| Colonic Neoplasms | 1 | 2000 | 122 | 0.150 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2009 | 45 | 0.150 |
Why?
|
| Hypoglycemic Agents | 2 | 2010 | 108 | 0.150 |
Why?
|
| Peptides | 3 | 2014 | 289 | 0.150 |
Why?
|
| Carbon Isotopes | 1 | 2018 | 43 | 0.140 |
Why?
|
| Injections, Intraocular | 1 | 2018 | 6 | 0.140 |
Why?
|
| Genes, Synthetic | 1 | 2018 | 5 | 0.140 |
Why?
|
| NADP | 1 | 2018 | 38 | 0.140 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 58 | 0.140 |
Why?
|
| Phospholipids | 1 | 2018 | 76 | 0.140 |
Why?
|
| Staining and Labeling | 1 | 2018 | 69 | 0.140 |
Why?
|
| Triglycerides | 1 | 2018 | 120 | 0.140 |
Why?
|
| Tomography, Optical Coherence | 1 | 2018 | 94 | 0.130 |
Why?
|
| Liver | 3 | 2009 | 441 | 0.130 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 101 | 0.130 |
Why?
|
| Adenoviruses, Human | 2 | 2008 | 22 | 0.130 |
Why?
|
| PPAR alpha | 1 | 2017 | 33 | 0.130 |
Why?
|
| Aging | 1 | 2024 | 976 | 0.130 |
Why?
|
| Polymers | 1 | 2018 | 117 | 0.130 |
Why?
|
| Biomarkers | 1 | 2020 | 763 | 0.130 |
Why?
|
| In Vitro Techniques | 4 | 2002 | 242 | 0.130 |
Why?
|
| Thymocytes | 1 | 2016 | 13 | 0.130 |
Why?
|
| Intravitreal Injections | 1 | 2016 | 34 | 0.130 |
Why?
|
| Down-Regulation | 2 | 2017 | 198 | 0.130 |
Why?
|
| Metal Nanoparticles | 1 | 2018 | 130 | 0.130 |
Why?
|
| Phosphatidylethanolamines | 1 | 2016 | 26 | 0.120 |
Why?
|
| Phosphatidylcholines | 1 | 2016 | 45 | 0.120 |
Why?
|
| Glutathione Transferase | 3 | 2005 | 33 | 0.120 |
Why?
|
| Stress, Physiological | 2 | 2009 | 96 | 0.120 |
Why?
|
| RNA Interference | 1 | 2016 | 137 | 0.120 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 2 | 2013 | 42 | 0.120 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2013 | 31 | 0.120 |
Why?
|
| Glucose | 1 | 2016 | 203 | 0.120 |
Why?
|
| Guanylate Cyclase-Activating Proteins | 1 | 2014 | 3 | 0.120 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2005 | 23 | 0.120 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2014 | 6 | 0.120 |
Why?
|
| Guanylate Cyclase | 1 | 2014 | 15 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 113 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2008 | 233 | 0.120 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 521 | 0.110 |
Why?
|
| Neuroprotective Agents | 2 | 2007 | 52 | 0.110 |
Why?
|
| Photochemistry | 1 | 2014 | 10 | 0.110 |
Why?
|
| Protamines | 1 | 2014 | 11 | 0.110 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 57 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 78 | 0.110 |
Why?
|
| Ischemia | 1 | 2015 | 84 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 134 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 114 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 1 | 2014 | 101 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2004 | 132 | 0.110 |
Why?
|
| Age Factors | 1 | 2016 | 733 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 149 | 0.110 |
Why?
|
| Biocompatible Materials | 1 | 2014 | 95 | 0.100 |
Why?
|
| Chromones | 3 | 2008 | 11 | 0.100 |
Why?
|
| Aged | 2 | 2020 | 5417 | 0.100 |
Why?
|
| Morpholines | 3 | 2008 | 28 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 329 | 0.100 |
Why?
|
| Molecular Weight | 3 | 2010 | 119 | 0.100 |
Why?
|
| Cloning, Molecular | 3 | 2009 | 207 | 0.100 |
Why?
|
| Physiology | 1 | 2012 | 8 | 0.100 |
Why?
|
| Protein Conformation | 2 | 2011 | 257 | 0.100 |
Why?
|
| DNA | 1 | 2014 | 374 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2005 | 281 | 0.100 |
Why?
|
| Macular Degeneration | 1 | 2013 | 84 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 123 | 0.090 |
Why?
|
| Ion Channel Gating | 1 | 2012 | 19 | 0.090 |
Why?
|
| Middle Aged | 2 | 2020 | 7164 | 0.090 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2012 | 30 | 0.090 |
Why?
|
| Myocardium | 3 | 2002 | 192 | 0.090 |
Why?
|
| Peptide Fragments | 2 | 2004 | 202 | 0.090 |
Why?
|
| Opsins | 1 | 2011 | 19 | 0.090 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 85 | 0.090 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2011 | 32 | 0.090 |
Why?
|
| Acyl Coenzyme A | 2 | 2002 | 12 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 2 | 2008 | 67 | 0.090 |
Why?
|
| Calmodulin-Binding Proteins | 2 | 2001 | 6 | 0.090 |
Why?
|
| Diglycerides | 1 | 2010 | 10 | 0.080 |
Why?
|
| Photobleaching | 1 | 2010 | 4 | 0.080 |
Why?
|
| Type C Phospholipases | 1 | 2010 | 31 | 0.080 |
Why?
|
| Oncogene Protein pp60(v-src) | 2 | 2000 | 6 | 0.080 |
Why?
|
| Protein Kinase C | 1 | 2010 | 73 | 0.080 |
Why?
|
| Threonine | 1 | 2010 | 20 | 0.080 |
Why?
|
| Eye Diseases | 1 | 2010 | 31 | 0.080 |
Why?
|
| Serine | 1 | 2010 | 50 | 0.080 |
Why?
|
| Caspase 3 | 1 | 2010 | 58 | 0.080 |
Why?
|
| Kidney | 1 | 2011 | 286 | 0.080 |
Why?
|
| Rats, Inbred Strains | 1 | 2009 | 63 | 0.080 |
Why?
|
| Rats, Wistar | 1 | 2009 | 151 | 0.080 |
Why?
|
| Transfection | 1 | 2010 | 318 | 0.080 |
Why?
|
| Sorbitol | 1 | 2009 | 3 | 0.080 |
Why?
|
| Osmotic Pressure | 1 | 2009 | 10 | 0.080 |
Why?
|
| Cornea | 2 | 2008 | 68 | 0.080 |
Why?
|
| Molecular Biology | 1 | 2009 | 17 | 0.080 |
Why?
|
| src Homology Domains | 2 | 2005 | 31 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 68 | 0.070 |
Why?
|
| Adenovirus Infections, Human | 1 | 2008 | 8 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2008 | 180 | 0.070 |
Why?
|
| Interleukin-8 | 1 | 2008 | 45 | 0.070 |
Why?
|
| Cholesterol | 1 | 2009 | 200 | 0.070 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 36 | 0.070 |
Why?
|
| Radiation Dosage | 1 | 2007 | 54 | 0.070 |
Why?
|
| Calpain | 3 | 2002 | 5 | 0.060 |
Why?
|
| beta-Cyclodextrins | 1 | 2006 | 9 | 0.060 |
Why?
|
| Estradiol | 2 | 2004 | 175 | 0.060 |
Why?
|
| Mutation | 1 | 2010 | 849 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2005 | 46 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2017 | 327 | 0.060 |
Why?
|
| Eukaryotic Cells | 1 | 2005 | 10 | 0.060 |
Why?
|
| GTP-Binding Proteins | 1 | 2005 | 46 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2005 | 50 | 0.060 |
Why?
|
| Hedgehog Proteins | 1 | 2005 | 33 | 0.060 |
Why?
|
| Glycine | 1 | 2005 | 31 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 66 | 0.060 |
Why?
|
| Cysteine | 1 | 2005 | 68 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2005 | 118 | 0.060 |
Why?
|
| Triticum | 1 | 2004 | 20 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2005 | 155 | 0.060 |
Why?
|
| Blotting, Northern | 2 | 2004 | 46 | 0.060 |
Why?
|
| 3T3-L1 Cells | 1 | 2004 | 29 | 0.060 |
Why?
|
| Antibodies | 2 | 2002 | 124 | 0.060 |
Why?
|
| Coloring Agents | 2 | 2004 | 35 | 0.050 |
Why?
|
| Cytoplasm | 2 | 2000 | 57 | 0.050 |
Why?
|
| Arabidopsis | 2 | 2004 | 67 | 0.050 |
Why?
|
| Lipoproteins | 1 | 2004 | 99 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2008 | 658 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2000 | 315 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 153 | 0.050 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2002 | 15 | 0.050 |
Why?
|
| Estrogens | 1 | 2003 | 56 | 0.050 |
Why?
|
| Coenzyme A | 1 | 2002 | 13 | 0.050 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2002 | 1 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2001 | 47 | 0.050 |
Why?
|
| Calcineurin | 1 | 2001 | 7 | 0.050 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2021 | 1 | 0.050 |
Why?
|
| Genes, src | 1 | 2000 | 4 | 0.040 |
Why?
|
| Genes, p53 | 1 | 2000 | 14 | 0.040 |
Why?
|
| Antibodies, Neoplasm | 1 | 2000 | 7 | 0.040 |
Why?
|
| Gallbladder | 1 | 2000 | 8 | 0.040 |
Why?
|
| Gene Amplification | 1 | 2000 | 22 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2000 | 27 | 0.040 |
Why?
|
| Introns | 1 | 2000 | 43 | 0.040 |
Why?
|
| Actin Cytoskeleton | 2 | 2016 | 24 | 0.040 |
Why?
|
| Genome, Plant | 1 | 2000 | 25 | 0.040 |
Why?
|
| Enzyme Precursors | 1 | 2000 | 16 | 0.040 |
Why?
|
| Carcinoma in Situ | 1 | 2000 | 46 | 0.040 |
Why?
|
| Rabbits | 1 | 2000 | 276 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2000 | 190 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 2000 | 73 | 0.040 |
Why?
|
| Survival Rate | 1 | 2000 | 430 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2000 | 139 | 0.040 |
Why?
|
| Time Factors | 1 | 2002 | 1593 | 0.030 |
Why?
|
| Retinal Neovascularization | 1 | 2017 | 20 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2000 | 465 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2000 | 297 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 133 | 0.030 |
Why?
|
| NF-kappa B | 2 | 2008 | 191 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1995 | 6 | 0.030 |
Why?
|
| Acetonitriles | 1 | 1995 | 2 | 0.030 |
Why?
|
| Frizzled Receptors | 1 | 2015 | 3 | 0.030 |
Why?
|
| Solvents | 1 | 1995 | 40 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 2021 | 0.030 |
Why?
|
| COS Cells | 1 | 2014 | 49 | 0.030 |
Why?
|
| Spleen | 1 | 1995 | 112 | 0.030 |
Why?
|
| Blotting, Southern | 2 | 2004 | 27 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 80 | 0.030 |
Why?
|
| Ethanol | 1 | 1995 | 123 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2000 | 2384 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 451 | 0.030 |
Why?
|
| Hydrogen Peroxide | 2 | 2004 | 144 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2004 | 132 | 0.020 |
Why?
|
| Inflammation | 1 | 2017 | 633 | 0.020 |
Why?
|
| Phylogeny | 2 | 2004 | 480 | 0.020 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2008 | 4 | 0.020 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2008 | 6 | 0.020 |
Why?
|
| Synaptotagmin I | 1 | 2008 | 5 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2008 | 11 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2008 | 38 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2008 | 48 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 123 | 0.020 |
Why?
|
| Gene Expression | 1 | 2008 | 416 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2005 | 21 | 0.020 |
Why?
|
| Myristic Acids | 1 | 2004 | 2 | 0.010 |
Why?
|
| Acylation | 1 | 2004 | 10 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2004 | 38 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2004 | 22 | 0.010 |
Why?
|
| Methionine | 1 | 2004 | 37 | 0.010 |
Why?
|
| Plants | 1 | 2004 | 68 | 0.010 |
Why?
|
| Acetylation | 1 | 2004 | 37 | 0.010 |
Why?
|
| Hippocalcin | 1 | 2004 | 4 | 0.010 |
Why?
|
| Recoverin | 1 | 2004 | 4 | 0.010 |
Why?
|
| Tetrazolium Salts | 1 | 2004 | 9 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 18 | 0.010 |
Why?
|
| Tamoxifen | 1 | 2004 | 33 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 62 | 0.010 |
Why?
|
| Thiazoles | 1 | 2004 | 51 | 0.010 |
Why?
|
| Progesterone | 1 | 2004 | 129 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 2002 | 32 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 608 | 0.010 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2002 | 1 | 0.010 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 1 | 1 | 2002 | 1 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2004 | 336 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2002 | 87 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2004 | 806 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 2000 | 31 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2000 | 60 | 0.010 |
Why?
|
| Plants, Genetically Modified | 1 | 2000 | 23 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2001 | 122 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2000 | 724 | 0.010 |
Why?
|